NUS
Nu Skin Enterprises Inc
4.60$
+0.2%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -2.0% | -14.6% | +5.2% | -2.0% | +3.6% | -18.2% | +5.9% | -5.7% | +1.7% | -13.4% | -0.2% | – | |
| – | -34.0% | -9.5% | +7.0% | -2.4% | +29.3% | -29.4% | +2.4% | -10.7% | +0.8% | -2.0% | -4.1% | – | |
| – | +20.6% | -16.6% | +4.5% | -1.9% | -7.4% | -11.5% | +7.6% | -3.4% | +2.0% | -18.1% | +1.8% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +10.8% | -14.1% | -5.3% | -2.0% | +4.6% | -6.4% | -5.7% | -1.8% | +2.5% | -8.2% | -7.8% | – | |
| – | +5.6% | -15.2% | +51.7% | -34.5% | +17.3% | -22.7% | -8.5% | +0.1% | +1.6% | -12.6% | +33.1% | – | |
| – | – | -45.1% | -1,523.2% | – | -391.2% | – | – | -29.7% | +7.4% | -74.8% | -1,111.4% | – | |
| – | -80.4% | +396.3% | -8.3% | -3.3% | -9.8% | -44.0% | -23.1% | +64.1% | -3.6% | +6.4% | -21.8% | – | |
| – | – | -88.2% | -12,057.1% | – | -534.7% | – | -79.6% | -41.7% | +13.7% | -85.7% | -2,530.7% | – | |
| – | -18.3% | -20.1% | -919.5% | – | -534.3% | – | -76.8% | -117.2% | – | -79.4% | +24,359.1% | – | |
| – | – | -107.3% | – | – | -534.9% | – | -80.4% | -19.1% | -15.2% | -87.3% | -13,705.6% | – | |
| – | – | +1.0% | -499.5% | – | -195.6% | – | -71.7% | -25.0% | +8.9% | -45.3% | -345.9% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.